Related Experiment Video
Updated: Apr 1, 2026
External Cephalic Version: Is it an Effective and Safe Procedure?
Published on: June 6, 2020
A comparison of recommendations for pharmacologic thromboembolism prophylaxis after caesarean delivery from three
K L Palmerola1, M E D'Alton1, C O Brock1
1Department of Obstetrics & Gynecology, Columbia University College of Physicians and Surgeons, New York, NY, USA.
Insights
Obstetric venous thromboembolism (VTE) prophylaxis guidelines vary significantly between major organizations. This study highlights the wide discrepancies in recommended VTE prophylaxis rates for women after caesarean delivery, underscoring the need for further research.
Area of Science:
- Obstetrics and Gynecology
- Thrombosis Research
- Clinical Guidelines
Background:
- Venous thromboembolism (VTE) is a significant risk in obstetric patients.
- Current guidelines for pharmacologic VTE prophylaxis from ACOG, RCOG, and Chest differ considerably.
- These variations pose practical challenges in managing VTE risk post-caesarean delivery.
Purpose of the Study:
- To evaluate the practical implications of differing VTE prophylaxis guidelines.
- To determine the impact of RCOG, ACOG, and Chest recommendations on prophylaxis rates in a tertiary obstetric population.
- To identify common risk factors for VTE in patients undergoing caesarean delivery.
Main Methods:
- A cross-sectional study was conducted at a tertiary referral hospital.
- Rates of pharmacologic prophylaxis were assessed for patients post-caesarean delivery based on RCOG, ACOG, and Chest guidelines.
- Medical, obstetric, and demographic risk factors were reviewed to calculate prophylaxis rates and confidence intervals.
Main Results:
- Under RCOG guidelines, 85.0% of patients would receive prophylaxis, compared to 1.0% under ACOG and 34.8% under Chest.
- Common risk factors identified included caesarean during labor, obesity, advanced maternal age, pre-eclampsia, and multiple gestation.
- Significant differences in recommended prophylaxis rates were observed across the evaluated guidelines.
Conclusions:
- Major society guidelines for post-caesarean thromboprophylaxis exhibit substantial variation.
- ACOG recommendations would result in minimal prophylaxis, while RCOG recommendations would lead to widespread use of low-molecular-weight heparin.
- Further research is crucial to compare the risks and benefits of these divergent recommendations for VTE prophylaxis.
Objective:
Guidelines for pharmacologic obstetric venous thromboembolism (VTE) prophylaxis from the American Congress of Obstetricians (ACOG), the Royal College of Obstetricians and Gynaecologists (RCOG), and the American College of Chest Physicians (Chest) vary significantly. The objective of this study was to determine the practical implications of these recommendations in terms of prophylaxis rates for a tertiary obstetric population.
Study Design:
Cross-sectional.
Setting:
Tertiary referral hospital.
Population:
Patients post-operative day 1 after caesarean delivery.
Methods:
This cross-sectional study evaluated rates of pharmacologic prophylaxis for women based on RCOG, ACOG, and Chest recommendations. Medical, obstetric, and demographic risk factors for thromboembolism were reviewed for individual patients. Rates of prophylaxis based on each of the guidelines with 95% confidence intervals were calculated.
Outcome Measure:
Recommended pharmacologic prophylaxis.
Results:
About 293 patients were included in the analysis. Under RCOG guidelines, 85.0% of patients would receive post-caesarean pharmacologic prophylaxis [95% confidence interval (CI) 80.5-88.6%] compared with 1.0% of patients under ACOG guidelines (95% CI 0.3-3.0%) and 34.8% of patients under Chest guidelines (95% CI 29.6-40.4%). Caesarean during labour, obesity, advanced maternal age, pre-eclampsia, and multiple gestation were among the most commonrisk factors.
Conclusion:
Recommended prophylaxis differed significantly. Under ACOG recommendations a small minority of patients would receive prophylaxis, whereas under RCOG recommendations a large majority of patients would receive low-molecular-weight heparin. Given the large differences in prophylaxis rates for post-caesarean thromboprophylaxis based on different guidelines, further research is urgently needed to compare the risks and benefits of recommendations.
Tweetable Abstract:
Recommendations from major society guidelines for post-caesarean thromboprophylaxis differ greatly.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
01:30Venous Thrombosis IV: Nursing Management
01:27Pulmonary Embolism III: Nursing Management
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...